Delivery Order SPE2DE22D0008-SPE2D626F7122
Award Date 10/30/25
Potential Completion Date 11/4/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Alba Bioscience, Inc., a Chicago-based diagnostic supplier specializing in immunohematology reagents and blood banking materials, was awarded a $4,740 delivery order by the Defense Logistics Agency's Medical Supply Chain division on October 30, 2025, for ALBACLONE Anti-B monoclonal antibodies. The contract, utilizing firm fixed pricing with no set-aside designation, is scheduled for completion by November 4, 2025, and will be performed in Chicago, Illinois. This delivery order represents a...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order contract to Alba Bioscience, Inc. for ALBACLONE anti-FYB antibody screening products. The contract, valued at $12,875 with a firm fixed price structure, was executed on September 4, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside award represents a continuation of Alba Bioscience's established role as a critical supplier of specialized in vitro diagnostic...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,115.79 to Alba Bioscience, Inc. for the ALBACYTE Antibody ID Panel (16-Cell) on October 30, 2025, with an ultimate completion date of January 7, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting Alba Bioscience's competitive standing as a specialized supplier of immunohematology reagents and blood banking diagnostic materials. Alba Bioscience, a...
- Alba Bioscience, Inc. was awarded a delivery order valued at $1,123.00 by the Medical Supply Chain division of the Defense Department on July 29, 2025, with an ultimate completion date of August 1, 2025. The contract, identified as 4568920078, covers the supply of ALBACLONE Anti-A antibodies, specialized reagents used in blood banking and immunohematology testing. This non-set-aside award was issued under a firm fixed-price arrangement, with performance to be completed in Chicago, Illinois. Alba...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded Alba Bioscience, Inc. a $9,500 delivery order on October 30, 2025, for an ALBACYTE Antibody ID Panel (10-Cell) with a completion date of January 7, 2026. This firm fixed-price delivery order represents a competitive procurement without set-aside designation, leveraging Alba Bioscience's specialized capabilities in immunohematology reagents and blood banking diagnostics. Alba Bioscience, a Chicago-based subsidiary of...
- Alba Bioscience, Inc. was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain division on August 14, 2025, for the supply of ALBACLONE Anti-D Blend, a specialized blood bank reagent used in immunohematology testing. This firm fixed-price contract carries a ceiling value of $1,464.00 with an ultimate completion date of August 19, 2025. The contract was awarded on a non-competitive basis with no set-aside designation, reflecting Alba Bioscience's established...
- The Defense Logistics Agency, operating under the Defense or Civilian designation, awarded a delivery order contract (4568409675) to Alba Bioscience, Inc. on June 2, 2025, for the supply of ALBACLONE Anti-K antibodies. The contract represents a firm fixed price delivery order with a ceiling value of $15,944.00 and an ultimate completion date of June 5, 2025. The award was made on a non-set-aside basis, reflecting Alba Bioscience's competitive standing as an established supplier of specialized...
- Alba Bioscience, Inc. was awarded a delivery order valued at $6,270 on September 4, 2025, for the ALBACYTE Antibody ID Panel (10-Cell) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain division. The contract is scheduled for completion by November 7, 2025, and will be performed at the contractor's facility in Chicago, Illinois. This non-set-aside award represents Alba Bioscience's continued role as a critical supplier of specialized in vitro diagnostic...
- This federal contract award to Alba Bioscience, Inc., a subsidiary of Quotient Biodiagnostics, Inc., is for the delivery of ALBACLONE anti-B medical supplies. The $3,792.00 Firm Fixed Price contract was awarded on May 16, 2025 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of May 21, 2025. The contract is not designated as a set-aside. Alba Bioscience, Inc. is a for-profit organization specializing in in vitro diagnostics, blood bank reagents, and other...
- Alba Bioscience, Inc. received a $2,030 firm fixed-price delivery order from the Department of Defense's Medical Supply Chain on June 5, 2025, for the ALBACYTE Antibody ID Panel (16-Cell). The contract, which carries an ultimate completion date of August 11, 2025, was awarded without a set-aside designation, reflecting Alba Bioscience's competitive standing as a supplier of specialized in vitro diagnostic products. Performance will take place in Chicago, Illinois, where the vendor maintains...